Sclerosis (MS) is the most common disability in young adults that requires
early symptomatic treatment to prevent long-term disability. Among young
adults, MS is the most common central nerv-ous system (CNS) chronic
inflammatory illness that is characterized by demyelination in the CNS.
However, current disease-modifying treatments are not sufficiently effective
for preventing the variety of symptoms during the course of disease.
L. J., Allington, D. R., Procacci, K. A., Rivey, M. P., Barten, L. J.,
Allington, D. R., ... & Rivey, M. P. (2010). New approaches in the
management of multiple sclerosis. Drug Design, De-velopment and Therapy, 4,
Kim, E., Lovera, J., Schaben, L., Melara, J., Bourdette, D., &
Whitham, R. (2010). Novel method for measurement of fatigue in multiple
sclerosis: Real-Time Digital Fatigue Score. Journal of Re-habilitation Research
& Development, 47(5).
Sclerosis Society (2014, May), Feys, P., Gijbels, D., Romberg, A., Santoyo, C.,
Gebara, B., de Noordhout, B. M., & Dalgas, U. (2012). Effect of time of day
on walking capacity and self-reported fatigue in persons with multiple
sclerosis: a multi-center trial. Multiple Sclerosis Journal, 18(3),
351-357. Kennedy, P., & Hutchinson,
C. B. Mobility in Multiple Sclerosis.
Kim, E., Cameron, M., Lovera, J.,
Schaben, L., Bourdette, D., & Whitham, R. (2011). American ginseng does not
improve fatigue in multiple sclerosis: a single center randomized double-blind
placebo-controlled crossover pilot study. Multiple Sclerosis Journal, 17(12),
Kim, T. H.,
Yoon, S. J., Lee, W. C., Kim, J. K., Shin, J., Lee, S., & Lee, S. M.
(2011). Protective effect of GCSB-5, an herbal preparation, against peripheral
nerve injury in rats. Journal of Eth-nopharmacology, 136,2, 297-304.
P., Csurhes, P. A., Houghten, R. A., McCombe, P. A., & Good, M. F. (1996).
A study of human T-cell lines generated from multiple sclerosis patients and
controls by stimulation with peptides of myelin basic protein. Journal of
neuroimmunology, 70(1), 65-74.
H. J., Lee, H. S., Shin, J. S., Lee, S. H., Park, B. M., Youn, Y. S., &
Lee, S. K. (2010). Modulation of acute and chronic inflammatory processes by a
traditional medicine preparation GCSB-5 both in vitro and in vivo animal
models. Journal of ethnopharmacology, 130,3), 450-459.
Ruck, T., Bittner,
S., Simon, O. J., Gobel, K., Wiendl, H., Schilling, M., & Meuth, S. G.
(2013). Long-term effects of dalfampridine in patients with multiple sclerosis.
Journal of the neurological sciences.